Micro-Tech Endoscopy Announces LesionHunter Cold Snare

Micro-Tech Endoscopy launched the LesionHunter Cold Snare, a novel cold snare with an ultra-thin Nitinol wire. Key features include:

  • Thin Monofilament Nitinol Wire – this wire material provides durability in the shape and allows for a 0.18mm thin wire for a clean and precise cut.
  • Coiled Sheath – the coiled metal catheter creates greater stability for the guillotine-like cutting action of the wire.
  • Reduced Fly-Away Tissue – the thin wire may reduce the risk of generating a “fly-away” specimen; thereby making it easier to find the tissue at the end of the resection.

“The LesionHunter is a unique cold snare with two great features, the ability to trap the tissue regardless of how flat the lesion is, and the ‘cheese cutter’ capability to resect even larger lesions,” commented Gastroenterologist and Advanced Endoscopist at NYU Langone, Gregory Haber, M.D. “It has become my go-to for cold snare applications.”

The LesionHunter nitinol snare was specifically designed to advance cold snare polypectomy.

“The LesionHunter nitinol wire is 61% thinner than traditional braided snare wires and 42% thinner than the most popular braided cold snare on the market,” Micro-Tech’s Executive Global R&D Director Scott Haack said. “The thin Nitinol wire allows for multiple tissue resections while maintaining its shape along with the ability to make a clean cut through large pieces of tissue. Current dedicated cold snares and hybrid hot/cold snares can’t consistently accomplish this.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version